Mice in the NTC and MBC-005 treatment groups were evaluated for bioluminescent signaling at 6-, 13-, and 21-days after tumor inoculation. by Bryan S. Margulies (21492667)

Subjects:

The forest plot of subgroup analysis. by Hai-bo Ai (20790405)

“…When the rate was between 18% and 59%, medical costs decreased as the rate increased, and when the rate was < 18% or ≥  59%, medical costs did not decrease as the rate increased.…”

Disruption of <i>shk-1</i> increases susceptibility to bacterial pathogens. by Longjun Pu (20685717)

Inhibitor versus the normalized dose response curves. by Bryan S. Margulies (21492667)

Subjects:

Means, standard deviations, and inferential statistics for the outcomes in the three conditions tested. by Robert Trybulski (10998702)

Subjects:

Leg Stabilization During Measurements arterial occlusion pressure. by Robert Trybulski (10998702)

Subjects:

Example of LDF recording during post-occlusive reactive hyperemia (PORH). by Robert Trybulski (10998702)

Subjects:

CONSORT 2025 Flow Diagram [70]. by Robert Trybulski (10998702)

Subjects:

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Subjects:

Mean values and 95% confidence intervals for resting flow, arterial occlusion pressure (AOP), biological zero, reactive hyperemia (RHmax), and time to peak across the three conditi... by Robert Trybulski (10998702)

Subjects:

a) Number weighted mean volume of AEII during postnatal development and in adults. There are no volume alterations before and at the end of bulk alveolarization. A significant increase was determined in adults compared to 3 and 7 days old pups. b) Size of AEII presented as V_S-ratioAEII during postnatal lung development into adulthood. Before and during bulk alveolarization there are no size changes. Adults show a significant increase compared to values before and at onset of alveolarization. c) Number weighted mean volume of AEII per lung volume during postnatal development and in adults. The highest values are seen before alveolarization. During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21.... by Julia Hüttmann (22656283)

“…During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21. …”

Association between smoking status and incidence of cardiovascular and mortality outcomes stratified by enrollment year. by Erfan Tasdighi (9144667)

Subjects:

Baseline characteristics across conventional cigarette use status. by Erfan Tasdighi (9144667)

Subjects:

Graded association between pack-year groups in former and current smokers and cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)

Subjects:

Association between pack years of smoking and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline analysis. by Erfan Tasdighi (9144667)

Subjects:

CVD and mortality outcomes hazard ratio (HR) by years since quit smoking among former smokers compared with current and never smokers. by Erfan Tasdighi (9144667)

Subjects:

Cessation duration and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation. by Erfan Tasdighi (9144667)

Subjects:

Association between smoking status and incidence of cardiovascular and mortality outcomes among men. by Erfan Tasdighi (9144667)

Subjects:

Relationship between cigarettes per day and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation. by Erfan Tasdighi (9144667)

Subjects:

Association between the number of cigarettes per day with cardiovascular outcomes among current cigarette users. by Erfan Tasdighi (9144667)

Subjects: